Group | UA (μmol/L) | ESR (mm/h) | IL-1β (ng/L) | NALP3 (ng/L) | ||||
---|---|---|---|---|---|---|---|---|
Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | |
Observation group (n = 39) | 505.06 ± 54.97 | 339.20 ± 38.22a | 45.88 ± 8.54 | 16.63 ± 4.85a | 52.33 ± 9.25 | 32.94 ± 7.69a | 9.46 ± 1.79a | 7.08 ± 1.47a |
Control group (n = 39) | 515.18 ± 50.13 | 386.48 ± 40.69a | 45.92 ± 8.61 | 22.78 ± 5.10a | 53.50 ± 8.12 | 41.57 ± 8.83a | 9.86 ± 2.14a | 8.17 ± 1.77a |
t | 0.850 | 5.289 | 0.021 | 5.457 | 0.594 | 4.603 | 0.895 | 2.959 |
P | 0.398 | 0.000 | 0.984 | 0.000 | 0.555 | 0.000 | 0.373 | 0.004 |